• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载有吉西他滨的聚乙二醇化的单室脂质体与健择:体内分布、药代动力学特征和体内抗肿瘤活性。

Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity.

机构信息

Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Campus Universitario S. Venuta - Building of BioSciences, Viale Europa, I-88100 Germaneto (CZ), Italy.

出版信息

J Control Release. 2010 Jun 1;144(2):144-50. doi: 10.1016/j.jconrel.2010.02.021. Epub 2010 Feb 22.

DOI:10.1016/j.jconrel.2010.02.021
PMID:20184929
Abstract

The systemic efficacy of the chemotherapeutic agents presently used to treat solid tumors is limited by their low therapeutic index. Previously, our research group improved the in vitro antitumoral activity of gemcitabine, an anticancer agent rapidly deaminated to the inactive metabolite 2',2'-difluorodeoxyuridine, entrapping it into unilamellar pegylated liposomes made up of 1,2-dipalmitoyl-snglycero-3-phosphocholine monohydrate/cholesterol/N-(carbonyl-methoxypolyethylene glycol-2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine (6:3:1 molar ratio). In this work, we investigated the in vivo efficiency of the gemcitabine liposomal formulation (5mg/kg) with respect to the antitumoral commercial product GEMZAR (50mg/kg) on an anaplastic thyroid carcinoma xenograft model obtaining similar effects in terms of inhibition of tumor mass proliferation after 4weeks of treatment. The investigation of the carrier biodistribution and the drug pharmacokinetic profile furnished the rationalization of the efficacy of the vesicular system containing the active compound 10-fold less concentrated; in fact, liposomes promoted the concentration of the drug inside the tumor and they increased its plasmatic half-life. In addition, no signs of blood toxicity were observed when vesicular devices of effective doses of the drug were used.

摘要

目前用于治疗实体瘤的化疗药物的全身疗效受到其治疗指数低的限制。以前,我们的研究小组通过将阿糖胞苷(一种抗癌药物,迅速脱氨为无活性代谢物 2',2'-二氟脱氧尿苷)包封在由 1,2-二棕榈酰-snglycero-3-磷酸胆碱单水合物/胆固醇/N-(羰基-甲氧基聚乙二醇-2000)-1,2-二硬脂酰-snglycero-3-磷酸乙醇胺(6:3:1 摩尔比)组成的单室 PEG 化脂质体中来提高其体外抗肿瘤活性。在这项工作中,我们研究了阿糖胞苷脂质体制剂(5mg/kg)与抗肿瘤商业产品 Gemzar(50mg/kg)在间变性甲状腺癌异种移植模型中的体内效率,在治疗 4 周后,在抑制肿瘤质量增殖方面取得了相似的效果。载体生物分布和药物药代动力学特征的研究为含有活性化合物的囊泡系统的功效提供了合理化解释,因为该系统中药物的浓度低 10 倍;事实上,脂质体促进了药物在肿瘤内的浓度,并增加了其血浆半衰期。此外,当使用有效剂量的囊泡药物时,没有观察到血液毒性的迹象。

相似文献

1
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity.载有吉西他滨的聚乙二醇化的单室脂质体与健择:体内分布、药代动力学特征和体内抗肿瘤活性。
J Control Release. 2010 Jun 1;144(2):144-50. doi: 10.1016/j.jconrel.2010.02.021. Epub 2010 Feb 22.
2
Improved in vitro anti-tumoral activity, intracellular uptake and apoptotic induction of gemcitabine-loaded pegylated unilamellar liposomes.载吉西他滨的聚乙二醇化单层脂质体的体外抗肿瘤活性、细胞内摄取及凋亡诱导作用增强。
J Nanosci Nanotechnol. 2008 Apr;8(4):2102-13. doi: 10.1166/jnn.2008.065.
3
Cytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells.载吉西他滨脂质体对人间变性甲状腺癌细胞的细胞毒性作用。
BMC Cancer. 2004 Sep 13;4:63. doi: 10.1186/1471-2407-4-63.
4
In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer.载吉西他滨的聚乙二醇化小单层脂质体对胰腺癌的体内活性
Cancer Chemother Pharmacol. 2009 Oct;64(5):1009-20. doi: 10.1007/s00280-009-0957-1. Epub 2009 Mar 5.
5
Gemcitabine-loaded Folic Acid Tagged Liposomes: Improved Pharmacokinetic and Biodistribution Profile.载吉西他滨的叶酸标记脂质体:改善的药代动力学和生物分布特征。
Curr Drug Deliv. 2019;16(2):111-122. doi: 10.2174/1567201815666181024112252.
6
Comparative pharmacokinetic study of PEGylated gemcitabine and gemcitabine in rats by LC-MS/MS coupled with pre-column derivatization and MS technique.LC-MS/MS 结合柱前衍生化和 MS 技术在大鼠体内 PEG 化吉西他滨与吉西他滨的比较药代动力学研究。
Talanta. 2020 Jan 1;206:120184. doi: 10.1016/j.talanta.2019.120184. Epub 2019 Jul 27.
7
Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes.脂质组成和制备条件对载吉西他滨脂质体的物理化学性质、工艺参数及体外生物活性的影响
Curr Drug Deliv. 2007 Jan;4(1):89-101. doi: 10.2174/156720107779314749.
8
Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels.吉西他滨包封于囊泡状磷脂凝胶中后在人肿瘤异种移植模型中的药代动力学和药效学行为变化。
Cancer Chemother Pharmacol. 2002 May;49(5):356-66. doi: 10.1007/s00280-002-0428-4. Epub 2002 Mar 12.
9
Thermosensitive liposomes for the delivery of gemcitabine and oxaliplatin to tumors.热敏脂质体用于递送吉西他滨和奥沙利铂至肿瘤。
Mol Pharm. 2013 Dec 2;10(12):4499-508. doi: 10.1021/mp400321e. Epub 2013 Nov 11.
10
Gemcitabine-loaded innovative nanocarriers vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity.载吉西他滨创新纳米载体与健择的比较:生物分布、药代动力学特征和体内抗肿瘤活性。
Expert Opin Drug Deliv. 2011 Dec;8(12):1609-29. doi: 10.1517/17425247.2011.632630. Epub 2011 Nov 5.

引用本文的文献

1
Improved Antitumor Efficiency of -Tetradecyloxycarbonyl Gemcitabine-Loaded Liposomes for Pancreatic Cancer Chemotherapy.载有α-十四烷氧羰基吉西他滨的脂质体用于胰腺癌化疗的抗肿瘤效率提高
Int J Nanomedicine. 2024 Dec 11;19:13391-13410. doi: 10.2147/IJN.S485861. eCollection 2024.
2
Curcumin synergistically enhances the efficacy of gemcitabine against gemcitabine-resistant cholangiocarcinoma via the targeting LAT2/glutamine pathway.姜黄素通过靶向 LAT2/谷氨酰胺途径协同增强吉西他滨对吉西他滨耐药胆管癌的疗效。
Sci Rep. 2024 Jul 11;14(1):16059. doi: 10.1038/s41598-024-66945-7.
3
Liposomes: structure, composition, types, and clinical applications.
脂质体:结构、组成、类型及临床应用。
Heliyon. 2022 May 13;8(5):e09394. doi: 10.1016/j.heliyon.2022.e09394. eCollection 2022 May.
4
Emerging pro-drug and nano-drug strategies for gemcitabine-based cancer therapy.基于吉西他滨的癌症治疗的新兴前药和纳米药物策略。
Asian J Pharm Sci. 2022 Jan;17(1):35-52. doi: 10.1016/j.ajps.2021.06.001. Epub 2021 Jul 1.
5
Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer.水飞蓟素(奶蓟提取物)作为胃肠道癌症的治疗药物。
Biomed Pharmacother. 2021 Oct;142:112024. doi: 10.1016/j.biopha.2021.112024. Epub 2021 Aug 13.
6
A Liposomal Gemcitabine, FF-10832, Improves Plasma Stability, Tumor Targeting, and Antitumor Efficacy of Gemcitabine in Pancreatic Cancer Xenograft Models.一种脂质体吉西他滨(FF-10832)可提高胰腺癌异种移植模型中吉西他滨的血浆稳定性、肿瘤靶向性和抗肿瘤疗效。
Pharm Res. 2021 Jun;38(6):1093-1106. doi: 10.1007/s11095-021-03045-5. Epub 2021 May 7.
7
Nanotechnology improves the therapeutic efficacy of gemcitabine against a human hepatocellular carcinoma cell line and minimizes its in vivo side effects.纳米技术提高了吉西他滨对人肝癌细胞系的治疗效果,并最大限度地减少了其体内的副作用。
Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):631-643. doi: 10.1007/s00210-020-02004-y. Epub 2020 Oct 26.
8
Liposomal Delivery of Mycophenolic Acid With Quercetin for Improved Breast Cancer Therapy in SD Rats.载有槲皮素的霉酚酸脂质体递送用于改善SD大鼠的乳腺癌治疗
Front Bioeng Biotechnol. 2020 Jun 16;8:631. doi: 10.3389/fbioe.2020.00631. eCollection 2020.
9
Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis.新型药物联合纳米颗粒展现出增强的血浆暴露和剂量响应效应,可消除乳腺癌肺转移。
PLoS One. 2020 Mar 6;15(3):e0228557. doi: 10.1371/journal.pone.0228557. eCollection 2020.
10
Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach.基于生理的药代动力学建模与模拟方法分析纳米颗粒向肿瘤的递送
ACS Nano. 2020 Mar 24;14(3):3075-3095. doi: 10.1021/acsnano.9b08142. Epub 2020 Mar 4.